2021 Australian Pain Society Dr. Jeremy Henson

Can improved mucosal absorption allow a THC/CBD oro-buccal spray to achieve clinical efficacy in chronic pain?


Innovating Humanity

The past decade has significantly changed the world we live in; specifically looking at events surrounding the global opioid crisis and now COVID-19, the medical offerings for treatment, risk control and subsequent management have been found wanting. The medical/pharmaceutical industries are ripe for innovation as new threats plague our existence, suggesting our lack of readiness to combat our immediate needs may offer insights into our readiness (or lack thereof) for other potential impacts. With chronic illnesses on the rise, these medical crisis’s adds to the overall human and economic burden. This presentation looks at the path, discusses examples of innovation Medlab has undertaken, and theorises the future and its needs. Irrespective of specifics, innovation in medicine, drug design and regulatory models are much needed to ensure the health and safety of the future human race.


NeuroLogical pain drugs from cannabis

Dr Sean Hall, CEO of Medlab presents on Potentiating new NeuroLogical pain drugs from cannabis


Cannabis-based clinical research update

An update on the cannabis-based clinical research programme.


Understanding the Clinical Applications of NanoCelle

What are nanoparticles, and their applications in medicine Safety of nanotechnology NanoCelle - what is it? Oro-buccal delivery Medlab's B12 comparative data